Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Res Int ; 2017: 4867060, 2017.
Article in English | MEDLINE | ID: mdl-29201906

ABSTRACT

Risk assessment for pulmonary embolism (PE) currently relies on physician judgment, clinical decision rules (CDR), and D-dimer testing. There is still controversy regarding the role of D-dimer testing in low or intermediate risk patients. The objective of the study was to define the role of clinical decision rules and D-dimer testing in patients suspected of having a PE. Records of 894 patients referred for computed tomography pulmonary angiography (CTPA) at a University medical center were analyzed. The clinical decision rules overall had an ROC of approximately 0.70, while signs of DVT had the highest ROC (0.80). A low probability CDR coupled with a negative age-adjusted D-dimer largely excluded PE. The negative predictive value (NPV) of an intermediate CDR was 86-89%, while the addition of a negative D-dimer resulted in NPVs of 94%. Thus, in patients suspected of having a PE, a low or intermediate CDR does not exclude PE; however, in patients with an intermediate CDR, a normal age-adjusted D-dimer increases the NPV.


Subject(s)
Fibrin Fibrinogen Degradation Products/metabolism , Pulmonary Embolism/diagnosis , Pulmonary Embolism/metabolism , Aged , Computed Tomography Angiography/methods , Decision Making , Female , Fibrin Fibrinogen Degradation Products/immunology , Fibrin Fibrinogen Degradation Products/isolation & purification , Humans , Male , Middle Aged , Predictive Value of Tests , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/physiopathology , Risk Assessment
SELECTION OF CITATIONS
SEARCH DETAIL
...